The
global Unilateral Biportal Endoscopy Market size is
expected to reach USD 1.3 billion by 2030, according to a new report by Grand
View Research, Inc. The market is expected to expand at a CAGR of 6.4% from
2022 to 2030. Increasing demand for minimally invasive surgeries and the
growing awareness of the benefits such as reduced hospitalization, minimal
collateral tissue damage, reduced postoperative complications, and faster
recovery. Moreover, surgeons and their practices are transitioning from
conventional open procedures to robotic assisted and visually advanced
endoscopic procedures. Furthermore, technology advancements in the field
of spinal endoscopic procedures and minimally invasive surgeries are expected
to bolster market growth. For instance, June 2017, Olympus introduced 3D
surgical endoscope, which is compatible with VISERA ELITE II system. It uses 3D
imaging that helps with in depth perception for precision in surgery.
The
on-going Covid-19 pandemic has burdened healthcare systems across the globe and
has led to significant transformations in the healthcare industry, thereby
forcing endoscopy facilities to reduce volumes of elective and non-essential
endoscopic procedures. For instance, a survey conducted for endoscopy units
across 55 countries by the World Endoscopy Organization between April 2020 and
May 2020, reported an 87.0% reduction of in the number of endoscopy procedures.
The ongoing pandemic has caused alterations in the operating room structures,
workforce, indications, and pre-op setup. The alarming decline in endoscopic
procedures was recorded in emerging economies with developing healthcare
facilities.
In
2021, the reusable product type segment accounted for the largest revenue share
owing to the widespread adoption of these products due to their recoverability
rate through disinfection and sterilization. The bifurcation of these products
based on the exposure of infection risk into critical, semi-critical, and
non-critical devices enables selecting the appropriate disinfection process.
On the other hand, single use product type segment is anticipated
to register the fastest growth during the forecast period owing to the
increasing incidence of hospital acquired infections due to reusable products.
In addition, single use products are low on maintenance cost and storage, which
is expected to propel the growth of this segment. Lastly, this product segment
is witnessing a rise in adoption levels to curb the incidences of
cross-contamination.
Based
on the application, the decompression segment accounted for the highest revenue
share in 2021 owing to its minimally invasive nature and enhanced visualization
of discs and nerves is contributing to the growth of this segment. The various
forms of decompression procedures provide more favorable outcomes and minimum
complications, thereby boosting growth. In addition to decompression techniques
available for varied indications, degenerative lumbar canal stenosis recorded
the highest revenue share in 2021 owing to the multiple benefits of
decompression procedures such as prevention of paraspinal muscle atrophy,
reduced muscle dissection, and retraction.
Based
on end-user, the hospitals segment accounted for the largest revenue share in
2021 owing to large-scale adoption of these endoscopic procedures and growing demand
for minimally invasive surgeries. On the other hand, ambulatory surgery
centers/clinics are anticipated to be the fastest growing segment during the
forecast period owing to increasing preference for minimally invasive surgeries
and reduced hospitalization. The growing trend of same day surgery has resulted
in significant cost savings and optimum care delivery in the developed
economies and is therefore expected to boost segment growth.
In
2021, North America dominated the market. This can be attributed to developed
healthcare infrastructure, high adoption of advanced technologies, and an
increase in awareness about the advantages of minimally invasive therapies. On
the other hand, Asia Pacific is expected to be the fastest-growing region
during the forecast period owing to increasing investments by market players
for geographic expansion and rapid economic development in countries such as
China and India and improving health infrastructure in this region. Moreover,
the prevalence of spinal disorders in the geriatric population is the highest
in this region due to the presence of largest proportion of the geriatric
population.
Related Press
Release@ Unilateral
Biportal Endoscopy Market Report
List of Key Players in Unilateral Biportal
Endoscopy Market
- Endovision Co. Ltd.
- Karl Storz
- Smith & Nephew
- Stryker Corporation
- CONMED Corporation
- Maxer Endoscopy GmbH
- Joimax GmbH
- Richard Wolf
- Jiangsu Bonss Medical Technology Co. Ltd.
- Kinetix Lifesciences
Unilateral Biportal Endoscopy Market Report Highlights
- The market
size is anticipated to be valued at USD 1.3 billion by 2030, owing to
increasing demand for minimally invasive surgeries and advancements in
endoscopic visualization systems
- The reusable
product segment dominated the market in 2021 owing to the high
recoverability rate with advanced disinfection and sterilization
techniques
- The
decompression application segment dominated the market in 2021, owing to
its minimal invasive nature and quicker recovery time
- The hospital
segment dominated the market in 2021 owing to large scale adoption of
endoscopic procedures and catering to the rising demand of minimally
invasive surgeries
- North
America dominated the market in 2021 owing to well-established healthcare
facilities and technological advancements in endoscopic techniques
Related Reports@
Endoscopy Visualization Systems Market
Unilateral Biportal Endoscopy Market Segmentation
Grand
View Research, Inc. has segmented the global unilateral biportal endoscopy
market report on the basis of product, application, end-user, and region:
Unilateral Biportal Endoscopy Product Outlook
(Revenue, USD Million, 2014 - 2030)
- Reusable
- Single use
Unilateral Biportal Endoscopy Application Outlook
(Revenue, USD Million, 2014 - 2030)
- Decompression
- Lumbar
Central Canal Stenosis
- Degenerative
Lumbar Canal Stenosis
- Lumbar
Spinal Stenosis
- Deherniation
- Spinal
Stabilization
- Others
Unilateral Biportal Endoscopy End-user Outlook
(Revenue, USD Million, 2014 - 2030)
- Hospitals
- Ambulatory
Surgery Centers/Clinics
- Other
end-users
Unilateral Biportal Endoscopy Regional Outlook
(Revenue, USD Million, 2014 - 2030)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Spain
- France
- Italy
- Russia
- Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Indonesia
- Malaysia
- Vietnam
- Latin
America
- Brazil
- Mexico
- Argentina
- Middle East
& Africa
- South
Africa
- Saudi
Arabia
- UAE
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals, materials,
healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment